Skip to main content
Standard Chemical & Pharmaceutical Co., Ltd. logo

Standard Chemical & Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 1720 ISIN · TW0001720001 TW Manufacturing
Open in API
Filings indexed 1,592 across all filing types
Latest filing 2026-05-13 Interim / Quarterly Rep…
Country TW Taiwan
Listing TW 1720

About Standard Chemical & Pharmaceutical Co., Ltd.

http://www.standard.com.tw

Standard Chemical & Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical manufacturer established in 1967. The company specializes in the research, development, production, and marketing of a wide range of pharmaceutical products, including generic Western medicines, Active Pharmaceutical Ingredients (APIs), and healthcare supplements. Its therapeutic portfolio covers diverse areas such as cardiovascular, metabolic, respiratory, anti-infective, and musculoskeletal systems, as well as dermatological and urogenital treatments. As a prominent generic drug manufacturer, the company operates with an integrated business model that spans from high-tech R&D to brand management and distribution. Adhering to international quality standards and ISO 9001 certification, it focuses on technological innovation and sustainable growth to serve diverse healthcare needs across domestic and international markets.

Recent filings

Filing Released Lang Actions
115年第1季財務報告書 — 202601_1720_AI1.pdf
Interim / Quarterly Report Classification · 90% confidence The document is a consolidated financial report for the first quarter of the fiscal years 115 and 114, complete with an auditor’s (PwC) review opinion, full interim financial statements (balance sheet, income statement, cash flows, equity changes), and extensive notes. It covers a period shorter than a full fiscal year and contains substantive financial data rather than mere highlights or a publication announcement. This matches the definition of an Interim/Quarterly Report (IR). Q1 115
2026-05-13 Chinese
115年第1季權益變動表
Interim / Quarterly Report Classification · 90% confidence The document is a consolidated statement of changes in equity (“合併權益變動表”) for the company’s first quarter (民國115年第1季) and provides detailed interim financial data (equity balances, movements, net income, OCI, etc.). It contains substantive financial statements for a period shorter than a full fiscal year and is not merely an announcement or link to another report. Therefore, it qualifies as an Interim/Quarterly Report. Q1 2026
2026-05-13 Chinese
115年第1季現金流量表
Regulatory Filings Classification · 8% confidence The provided text is merely an inaccessible page error message containing no substantive corporate or financial content. It does not match any specific filing category and thus defaults to the fallback category for miscellaneous regulatory filings.
2026-05-13 Chinese
115年第1季綜合損益表
Regulatory Filings Classification · 9% confidence The document contains only a webpage access error message and no substantive corporate filing content. It does not fit any specific filing category and serves as a generic web error notice. Classified as Regulatory Filings (RNS) as the fallback category.
2026-05-13 Chinese
115年第1季資產負債表
Interim / Quarterly Report Classification · 90% confidence The document is the actual consolidated balance sheet for the first quarter (115年第1季) with detailed line items and comparative periods. It contains substantive financial data for a period shorter than a full fiscal year and is not merely an announcement or link to a report. Therefore it fits the definition of an Interim/Quarterly Report. Q1 2026
2026-05-13 Chinese
代子公司「江蘇生達生技醫藥有限公司」公告資金貸與 超限改善計畫執行情形
Regulatory Filings Classification · 85% confidence The document is a regulatory disclosure on the company’s public information platform “公開資訊觀測站,” reporting a subsidiary’s over-limit intercompany fund lending and its corrective plan under clause 51 of securities rules. It does not contain financial statements or represent an investor presentation, earnings release, or full report, but is a compliance announcement. Therefore it falls under the general Regulatory Filings category (RNS).
2026-05-12 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.